Podcast Index
Parcourez les podcasts par catégorie, ouvrez les épisodes récents et téléchargez l’audio pour l’écouter hors ligne.
Breast Cancer Update
Dr. Neil Love
Misjonen med Antonsen og Golden
P4-gruppen
The Way - A Christian Forward Movement
JOHN FRAHM
PodcastGemist
Podcast Gemist
Chicago Bulls Central
The B.R.E.A.K.S Media
Buy the dip
Buy the dip
Headline News
China Plus
Gardening With Angelo
Angelo Petiti (WTAMAM)
赚钱认知｜持续赚钱的心法
甄琦学长
Liberty and Prosperity
Seth Grossman
Podcast – Liberty and Prosperity
Seth Grossman
20/20
ABC News
Ein Land, 50 Gesichter - wie Deutsche in den USA leben
Thore Ziebell
人生まだ終わらんラジオ7/30の20:00お茶会開催決定
はまゆみ70・
Real Estate News Today | 2 Min News | The Daily News Now!
The Daily News Now!
Quantum
Fanny BOUTON et Olivier EZRATTY
Jovem Pan Top News
Jovem Pan
PHLY Philadelphia Sixers Podcast
ALLCITY Network, PHLY Sports
Baseball Dugout
Baseball Dugout
Clap If You Don't Care
Ricky G and Eric Krueger
Startupeable: Emprendimiento | Tecnología | Venture Capital
Enzo Cavalie
Man Talk Podcast
Man Talk Podcast
L'analista della comunicazione
Patrick Facciolo
Geek Forever’s Podcast
tharadhol
糗事大本营｜精选爆笑段子集
薯条酱
Osho Hindi Podcast
Govind Das Swami
Time to BS Podcast
Belly Up Media Network🎙️
GeekWire
GeekWire
The Unstoppable 5%
Laurie Drummond
Neon Jazz Interviews
Neon Jazz Interviews - The Finest Jazz Musicians From All Over the Globe
Danilo Torresi
Danilo Torresi
Blurt Vibes
UnmutedSoul
Storybox with Jamshed Qamar Siddiqui
Aaj Tak Radio
Courageous Leadership with Virginia Prodan
Virginia Prodan
The Wrestling News
Arcadian Vanguard
Le Show du Matin Week-End
Carl Boissonnault
Tout
Dr. Neil Love
Featuring perspectives from Dr Sara A Hurvitz, Dr Erica Mayer, Dr Joyce O’Shaughnessy, Dr Sara M Tolaney and Dr Nicholas Turner, moderated by Dr Tolaney, including the following topics:Introduction (0:00)Current and Futu...
Featuring an interview with Prof Dr Sibylle Loibl, including the following topics:Perspectives on overall survival gains achieved over the years for patients with metastatic breast cancer (mBC) (0:00)Previous treatment a...
Featuring perspectives from Dr Harold J Burstein and Dr Joyce O’Shaughnessy, including the following topics:Introduction: ODAC — April 30, 2026 (00:00)Adjuvant CDK4/6 Inhibitors (13:03)Adjuvant Oral Selective Estrogen Re...
Featuring perspectives from Ms Courtney Arn, Ms Jamie Carroll, Dr Edward B Garon, Dr Heather McArthur and Dr Kathleen N Moore, moderated by Dr Moore, including the following topics:Introduction (0:00)Overview of Antibody...
Featuring perspectives from Prof Giuseppe Curigliano, Prof Rebecca A Dent, Dr Erika Hamilton, Prof Nadia Harbeck and Dr Hope S Rugo, moderated by Dr Rugo, including the following topics:Introduction (00:00)Evolving Role ...
Featuring perspectives from Dr Erika Hamilton, Dr Jane Lowe Meisel, Dr Joyce O’Shaughnessy and Dr Seth Wander, including the following topics:Introduction (0:00)Current and Future Management of HR-Positive, HER2-Negative...
Featuring perspectives from Dr Kevin Punie and Dr Tiffany A Traina, including the following topics: Introduction: Where We Are; Where We’re Heading (0:00)First-Line Treatment of BRCA Wild-Type Disease (9:14)First-Line Tr...
Featuring perspectives from Dr Erika Hamilton and Dr Shanu Modi, including the following topics:Introduction (0:00)Considerations in the Care of Patients with Localized HER2-Positive Breast Cancer — Dr Modi (0:58)Contemp...
Featuring an interview with Prof Bernd Kasper, including the following topics:Case: A woman in her early 30s develops a progressing desmoid tumor in her abdomen during pregnancy(0:00)Case: A woman in her late 30s with a ...
Featuring perspectives from Dr Adam M Brufsky and Dr Kevin Kalinsky, including the following topics:Introduction (0:00)Current and Future Role of TROP2-Directed Antibody-Drug Conjugates in Therapy for Triple-Negative Bre...
Dr Sara A Hurvitz from the Fred Hutchinson Cancer Center in Seattle, Washington, and Dr Virginia Kaklamani from the UT Health San Antonio MD Anderson Cancer Center in San Antonio, Texas, discuss patient cases and review ...
Prof Bernd Kasper from the Mannheim Cancer Center in Mannheim, Germany, discusses recent updates on available and novel treatment strategies for desmoid tumors.CME information and select publications here.
Dr Aditya Bardia from the University of California Los Angeles and Dr Erica Mayer from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss key clinical trial data surrounding the use of oral SERDs in the manag...
Dr Seth Wander from Massachusetts General Hospital in Boston discusses the role of biomarker assessment in the management of HR-positive metastatic breast cancer. CME information and select publications here.
Dr Virginia F Borges from the University of Colorado Anschutz Medical Campus in Aurora and Dr Ian E Krop from Yale Cancer Center in New Haven, Connecticut, review clinical research data and best practices guiding the sel...
Dr Ravin Ratan from The University of Texas MD Anderson Cancer Center in Houston discusses available clinical data with treatment approaches for desmoid tumors, alongside clinical cases illustrating real-world applicatio...
Ms Jaime Carroll from Mayo Clinic in Rochester, Minnesota, Professor Giuseppe Curigliano from the European Institute of Oncology in Milan, Italy, Dr Marie E McDonnell from Brigham and Women’s Hospital in Boston, Massachu...
Dr Lajos Pusztai from Yale Cancer Center in New Haven, Connecticut, discusses recent developments with circulating tumor DNA assays in the management of breast cancer.CME information and select publications here.
Dr Ravin Ratan from The University of Texas MD Anderson Cancer Center in Houston discusses available clinical data with treatment approaches for desmoid tumors, alongside clinical cases illustrating real-world applicatio...
Dr Hope S Rugo from City of Hope Comprehensive Cancer Center in Duarte, California, and Dr Sara M Tolaney from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss key clinical trial data with antibody-drug con...
Remplissez le formulaire ci-dessous. Veillez à sélectionner à la fois Pays et Genres.
Envoyez-nous un message ci-dessous. Nous vous répondrons dans les 24 heures.